JP2025501768A5 - - Google Patents

Info

Publication number
JP2025501768A5
JP2025501768A5 JP2024538396A JP2024538396A JP2025501768A5 JP 2025501768 A5 JP2025501768 A5 JP 2025501768A5 JP 2024538396 A JP2024538396 A JP 2024538396A JP 2024538396 A JP2024538396 A JP 2024538396A JP 2025501768 A5 JP2025501768 A5 JP 2025501768A5
Authority
JP
Japan
Prior art keywords
sequence
promoter
mature
aav
raav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501768A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/082383 external-priority patent/WO2023122803A1/en
Publication of JP2025501768A publication Critical patent/JP2025501768A/ja
Publication of JP2025501768A5 publication Critical patent/JP2025501768A5/ja
Pending legal-status Critical Current

Links

JP2024538396A 2021-12-24 2022-12-24 ラミンa関連欠損症に対する遺伝子療法 Pending JP2025501768A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163293680P 2021-12-24 2021-12-24
US63/293,680 2021-12-24
PCT/US2022/082383 WO2023122803A1 (en) 2021-12-24 2022-12-24 Gene therapy for lamin a - associated deficiencies

Publications (2)

Publication Number Publication Date
JP2025501768A JP2025501768A (ja) 2025-01-23
JP2025501768A5 true JP2025501768A5 (cg-RX-API-DMAC10.html) 2026-01-07

Family

ID=86903820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538396A Pending JP2025501768A (ja) 2021-12-24 2022-12-24 ラミンa関連欠損症に対する遺伝子療法

Country Status (11)

Country Link
US (1) US20250049949A1 (cg-RX-API-DMAC10.html)
EP (1) EP4453226A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025501768A (cg-RX-API-DMAC10.html)
KR (1) KR20240118821A (cg-RX-API-DMAC10.html)
CN (1) CN118434877A (cg-RX-API-DMAC10.html)
AU (1) AU2022419657A1 (cg-RX-API-DMAC10.html)
CA (1) CA3241202A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024008188A2 (cg-RX-API-DMAC10.html)
IL (1) IL313734A (cg-RX-API-DMAC10.html)
MX (1) MX2024007903A (cg-RX-API-DMAC10.html)
WO (1) WO2023122803A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4634394A2 (en) 2022-12-17 2025-10-22 The Trustees of The University of Pennsylvania Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
WO2025007046A1 (en) 2023-06-29 2025-01-02 The Trustees Of The University Of Pennsylvania Mutant aav with central nervous system targeting motifs and compositions containing same
WO2025075551A1 (en) * 2023-10-06 2025-04-10 National University Of Singapore Method of treating lmna dilated cardiomyopathy
KR20260114566A (ko) 2023-11-14 2026-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심근 및 골격근-특이적 표적화 모티프를 갖는 조성물 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291699B2 (en) * 2003-03-18 2007-11-06 The Regents Of The University Of Colorado Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders
WO2013071047A1 (en) * 2011-11-11 2013-05-16 Children's Medical Center Corporation Compositions and methods for in vitro transcription of rna
US12404522B2 (en) * 2018-01-19 2025-09-02 Agency For Science, Technology And Research Disrupting the LINC complex for treating laminopathy
WO2020176896A1 (en) * 2019-02-28 2020-09-03 Encoded Therapeutics, Inc. Compositions and methods for treating laminopathies
EP4198053A1 (en) * 2021-12-15 2023-06-21 Universitätsklinikum Hamburg-Eppendorf Lmna gene expression for treatment of laminopathies

Similar Documents

Publication Publication Date Title
JP2022078208A5 (cg-RX-API-DMAC10.html)
JP2022530656A5 (cg-RX-API-DMAC10.html)
JP2022530633A5 (cg-RX-API-DMAC10.html)
JP2022530544A5 (cg-RX-API-DMAC10.html)
JP2026027271A5 (cg-RX-API-DMAC10.html)
US9540659B2 (en) Modified adeno-associated virus vector compositions
JP2020510429A5 (cg-RX-API-DMAC10.html)
JP2022511348A (ja) Aavトリプルプラスミドシステム
JP2021515548A5 (cg-RX-API-DMAC10.html)
IL259595B2 (en) Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
JP2014239686A5 (cg-RX-API-DMAC10.html)
JP2023529855A (ja) Smn1タンパク質をコードするコドン最適化した核酸およびその使用
JP2024532262A5 (cg-RX-API-DMAC10.html)
KR20240095165A (ko) 근이영양증의 치료
JP2024542950A5 (cg-RX-API-DMAC10.html)
JP2023548838A5 (cg-RX-API-DMAC10.html)
US20230055381A1 (en) Adeno-associated virus packaging systems
WO2025011566A1 (zh) 一种用于过敏性疾病的基因治疗载体核酸构建体及其使用方法
AR123948A1 (es) ANTICUERPOS ANTI-TNF-a VECTORIZADOS PARA INDICACIONES OCULARES
JP2022552892A5 (cg-RX-API-DMAC10.html)
WO2023240158A2 (en) Mutant adeno-associated virus (aav) capsids
JP2024519175A5 (cg-RX-API-DMAC10.html)
US20210292373A1 (en) Aav vp1u chimeras
KR20250108100A (ko) Aav 유전자 치료법 벡터를 이용한 심근병증의 치료
CN119894919A (zh) 包含来自三种不同辅助病毒的辅助元件的嵌合辅助核酸分子